Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care



Rating:

Share or cite this content

Citations should be made in the following way:
M. Villalobos (Heidelberg, Germany). Integration of palliative care from the very beginning to the very end in a patient with metastasised non-small cell lung cancer. International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care

Member's Comments

No comment yet.

Related content which might interest you: The role of palliative radiotherapy in locally advanced non small cell lung cancer Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Expressed wishes and incidence of euthanasia in advanced lung cancer patients}, Source: Eur Respir J 2012; 40: 949-956 Year: 2012 The optimal treatment of stage I nonsmall cell lung cancer in the era of SABR and modern day lung resections Source: Eur Respir J, 56 (5) 2002595; 10.1183/13993003.02595-2020 Year: 2020 Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care? Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Radiotherapy with curative intent for stage I and II non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Delays in the diagnosis and treatment of non-small cell lung cancer Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight Year: 2021 Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 Interdisciplinary multimodality management of stage III nonsmall cell lung cancer Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019 Year: 2019 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011 Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Adjuvant chemotherapy in stage Ib of non-small cell lung cancer (NSCLC)-experience of a pneumology department Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Second line therapy for advanced non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009